Drugs & medicalClass II

Park Avenue Compounding recalls Fentanyl citrate, 2 mcg / ml / Ropivacaine, 0.2% in NS 150 mL, CII, 150 mL bag, Rx Only, Park Avenue Compounding, 3662 Park Ave, Saint…

CGMP Deviations: Revised interpretation of Acceptable Quality Level (AQL) results.

Read the official notice →
Date
2025-11-26
Country
United States
Brand
Park Avenue Compounding
Product
Fentanyl citrate, 2 mcg / ml / Ropivacaine, 0.2% in NS 150 mL, CII, 150 mL bag, Rx Only, Park Avenue Compounding, 3662 Park Ave, Saint…
Classification
Class II
Units
Distributed in Missouri
Category
Drugs & medical
Source
FDA · Drug

Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer

What to do

  1. Check the product name, strength and lot number against the official notice.
  2. Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
  3. Ask the pharmacy or supplier about a replacement or refund.

General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.

More Park Avenue Compounding recalls

  1. 2025-12-10
  2. US
All 2 Park Avenue Compounding recalls →

Other drugs & medical recalls in the United States

  1. 2025-11-26
  2. US
    Drugs & medicalClass I

    TMJ Solutions Inc recalls TMJ Bilateral Implant REF: CHG020 Sterile EO, Rx Only

    Patient-fitted temporomandibular joint implant contained discrepancy in screw hole position.

    FDA · DeviceTMJ Solutions IncUS: IL, OR, MS, TX, OK, UT, MA, MD, NY, PA, VA, FL, CA, MN, GA OUS: Canada,…Official notice →
  3. US
    Drugs & medicalClass I

    CareFusion 303, Inc. recalls BD Alaris infusion Pump Module 8100, REF: 8100; KIT, BEZEL ASSY 8100BD, REF: 49000437; KIT ASSY ONE PIECE BEZEL 8100, REF: 49000270. Used…

    If infusion pump is dropped or severely jarred this may damage the pump module bezel assembly, which can cause under-infusion, over-infusion, unregulated flow, or pump module failure to calibrate; so dropped/jarred…

    FDA · DeviceCareFusion 303, Inc.Worldwide distribution. US nationwide including Puerto Rico, Guam, American…Official notice →
  4. US
    Drugs & medicalClass I

    Otsuka ICU Medical LLC recalls POTASSIUM CHLORIDE Inj., 10 mEq total in 100 mL Flexible Container, Highly concentrated 100 mEq/L, Rx Only, ICU Medical, Inc., Lake…

    Labeling: Label Error on Declared Strength-The overwrap label may incorrectly identify the product as POTASSIUM CHLORIDE Inj. 10 mEq instead of POTASSIUM CHLORIDE Inj. 20 mEq

    FDA · DrugOtsuka ICU Medical LLCUS Nationwide.Official notice →
  5. US
    Drugs & medicalClass II

    DermaRite Industries, LLC recalls Lantiseptic, Skin Protectant, Lanolin USP 30%, packaged in a) 5g (0.17 oz) (NDC 61924-304-05), b)14.2g (0.5 oz)( NDC 61924-304-14), c)…

    CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.

    FDA · DrugDermaRite Industries, LLCNationwide in the USAOfficial notice →
  6. US
    Drugs & medicalClass II

    Zydus Pharmaceuticals (USA) Inc recalls Bromocriptine Mesylate Capsules, USP, 5 mg, 30 Capsules per bottle, Rx Only. Manufactured by: Zydus Lifesciences Ltd.,…

    Failed Impurities/Degradation Specifications: Out of Specification (OOS) result reported for 2- Bromoergine impurity of Bromocriptine Mesylate Capsules.

    FDA · DrugZydus Pharmaceuticals (USA) IncNationwide in the USAOfficial notice →
  7. US
See all drugs & medical recalls →